$Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis$

Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis

Abstract Background Type 2 diabetes mellitus (T2DM) is associated with myocardial fibrosis (MF), a major contributor to adverse cardiovascular outcomes. Cardiovascular magnetic resonance (CMR), specifically extracellular volume fraction (ECV) and native T1 mapping, offers a non-invasive approach to...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahmed Marey, Ali Alabdullah, Hossam Ghorab, Fatima Ali, Jawdat Abdulla, Akhil Narang, Muhammad Umair
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Series:	BMC Cardiovascular Disorders
Subjects:	Diabetes Myocardial fibrosis Extracellular volume fraction T1 mapping Cardiovascular magnetic resonance Diabetic cardiomyopathy
Online Access:	https://doi.org/10.1186/s12872-025-04496-z
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine
by: Bin Wan, et al.
Published: (2025-01-01)

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
by: Sarala Raj Murthi, et al.
Published: (2025-01-01)

Relationship Between Myocardial Strain and Extracellular Volume: Exploratory Study in Patients with Severe Aortic Stenosis Undergoing Photon-Counting Detector CT
by: Costanza Lisi, et al.
Published: (2025-01-01)

Epicardial Adipose Tissue and Left Ventricular Hypertrophy in Hypertensive Patients With Preserved Ejection Fraction: A Multicenter Retrospective Cohort Study
by: Runze Zhu, et al.
Published: (2025-01-01)

The role of NF-κB in diabetic cardiomyopathy
by: Huang-Jun Liu, et al.
Published: (2024-12-01)

The Effects of MicroRNAs on Cardiomyopathy in a Rat Model of Streptozotocin-induced Diabetes Mellitus
by: Aslıhan Şeyda DOĞAN, et al.
Published: (2025-01-01)

Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy
by: Minjeong Kim, et al.
Published: (2025-01-01)

Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
by: Brian P. Halliday, et al.
Published: (2022-06-01)

Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling
by: Bin Zhang, et al.
Published: (2025-01-01)

Utilization of Mean Platelet Volume for Predicting Ischemic Heart Disease in Diabetic and Non-Diabetic Patients
by: Maryam Arefnia, et al.
Published: (2025-01-01)

Research progress on the role of extracellular vesicles in the pathogenesis of diabetic kidney disease
by: Jiangyuan Jin, et al.
Published: (2024-12-01)

Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy
by: Xin-Yi Feng, et al.
Published: (2025-01-01)

Mechanism of mTOR/RILP-regulated autophagic flux in increased susceptibility to myocardial ischemia-reperfusion in diabetic mice
by: Jiyao Zhao, et al.
Published: (2025-01-01)

Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy
by: Andraz Cerar, et al.
Published: (2020-06-01)

Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
by: Elina Khattab, et al.
Published: (2025-01-01)

BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy
by: Feng Jiang, et al.
Published: (2025-01-01)

Multi-omics mechanical analysis of gut microbiota, carboxylic acids, and cardiac gene expression interaction triggering diabetic cardiomyopathy
by: Meixin Shi, et al.
Published: (2025-01-01)

PEDF Overexpression Ameliorates Cardiac Lipotoxicity in Diabetic Cardiomyopathy via Regulation of Energy Metabolism
by: Mao T, et al.
Published: (2025-01-01)

Advantages of using T1-mapping in cardiac magnetic resonance imaging in patients with acromegaly
by: Alina A. Almaskhanova, et al.
Published: (2024-12-01)

Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
by: Tácia Tavares Aquinas Liguori, et al.
Published: (2025-01-01)

Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
by: Wu Yanxia, et al.
Published: (2024-12-01)

Genetic Polymorphism in Peripartum Cardiomyopathy
by: Ivana Purnama Dewi, et al.
Published: (2021-12-01)

Immunomodulation effects of collagen hydrogel encapsulating extracellular vesicles derived from calcium silicate stimulated-adipose mesenchymal stem cells for diabetic healing
by: Yen-Hong Lin, et al.
Published: (2025-01-01)

Bacteroides Fragilis Exacerbates T2D Vascular Calcification by Secreting Extracellular Vesicles to Induce M2 Macrophages
by: Cong Chen, et al.
Published: (2025-02-01)

Cardiac magnetic resonance quantified epicardial fat volume is associated with complex coronary artery disease among diabetics
by: Shimaa Sayed Khidr, et al.
Published: (2025-02-01)

Genotype-phenotype insights of pediatric dilated cardiomyopathy
by: Ying Dai, et al.
Published: (2025-01-01)

Racial differences in takotsubo cardiomyopathy outcomes in a large nationwide sample
by: Raja Zaghlol, et al.
Published: (2020-06-01)

Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume in patients with diabetic retinopathy
by: Trisha Ghosh, et al.
Published: (2025-01-01)

Peripartum Cardiomyopathy: A Case Report
by: Ozlem Ece Basaran, et al.
Published: (2020-08-01)

Edaravone dexborneol alleviates pericyte-mediated fibrosis depositing extracellular matrix through TGF-β1/IL-11 in cerebral small vessel disease
by: Qingrui Duan, et al.
Published: (2025-02-01)

Research Progress of Perioperative Anesthesia Management in Patients with Hypertrophic Cardiomyopathy
by: LIN Shuantong, et al.
Published: (2025-01-01)

Cardiovascular function shows early impairment in asymptomatic adolescents diagnosed with type 1 diabetes mellitus: an ultrasound-derived myocardial work study
by: Martina Ghirardo, et al.
Published: (2025-02-01)

Nationwide Outcomes of Heart Transplantation for Postpartum Cardiomyopathy
by: Ilias P. Doulamis, et al.
Published: (2025-01-01)

A case of silent myocardial ischemia associated with severe and prolonged hypoglycemia
by: Antonio Villa1, et al.
Published: (2019-03-01)

Isoproterenol mechanisms in inducing myocardial fibrosis and its application as an experimental model for the evaluation of therapeutic potential of phytochemicals and pharmaceuticals
by: Lujain Bader Eddin, et al.
Published: (2025-01-01)

Hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm
by: N.D. Oryshchyn, et al.
Published: (2016-11-01)

The influence of HIV infection on myocardial fibrosis diagnosed by cardiac magnetic resonance imaging in adults: a systematic review and meta-analysis of observation studies
by: Katongo Hope Mutengo, et al.
Published: (2025-01-01)

Features of cardiovascular magnetic resonance native T1 mapping in maintenance hemodialysis patients and their related factors
by: Changqin Zhang, et al.
Published: (2024-12-01)

Criteria of eligibility of patients with ischemic cardiomyopathy for revascularization and other surgical procedures
by: N.D. Oryshchyn
Published: (2016-09-01)

Factors determining quality of life of patients with ischemic cardiomyopathy selected for revascularization procedures
by: N.B. Іvaniuk, et al.
Published: (2016-09-01)